Glucocorticoid effects on adrenal steroids and cytokine responsiveness in polymyalgia rheumatica and elderly onset rheumatoid arthritis

Annals of the New York Academy of Sciences

Volumn 1069, Issue , 2006, Pages 307-314

  Sulli, Alberto ^a   Montecucco, Carlo Maurizio ^b   Caporali, Roberto ^b   Cavagna, Lorenzo ^b   Montagna, Paola ^a   Capellino, Silvia ^a   Fazzuoli, Laura ^c   Seriolo, Bruno ^a   Alessandro, Calvia ^a   Secchi, Maria Elena ^a   Cutolo, Maurizio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Cytokines; Elderly onset rheumatoid arthritis; Hormones; Polymyalgia rheumatica; Rheumatoid arthritis

Indexed keywords

CORTICOSTEROID; CYTOKINE; GLUCOCORTICOID; HYDROCORTISONE; HYDROXYPROGESTERONE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; PRASTERONE SULFATE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA;

AGED; CLINICAL ARTICLE; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NEUROENDOCRINE SYSTEM; ONSET AGE; PATHOGENESIS; PELVIC GIRDLE; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SHOULDER;

EID: 33745610427     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1351.029     Document Type: Conference Paper

References (23)

1. SALVARANI, C., F. CANTINI, L. BOIARDI, et al. 2004. Polymyalgia rheumatica. Best. Pract. Res. Clin. Rheumatol. 18: 705-722.
2. CIMMINO, M.A., G. MOGGIANA, C. MONTECUCCO, et al. 1994. Long term treatment of polymyalgia rheumatica with deflazacort. Ann. Rheum. Dis. 53: 331-333.
3. NARVAEZ, J., J.M. NOLLA-SOLE, J.A. NARVAEZ, et al. 2001. Musculoskeletal manifestations in polymyalgia rheumatica and temporal arteritis. Ann. Rheum. Dis. 60: 1060-1063.
4. HEALEY, L.A. 1992. Polymyalgia rheumatica and seronegative rheumatoid arthritis may be the same entity. J. Rheumatol. 19: 270-272.
5. BAJOCCHI, G., R. LA CORTE, A. LOCAPUTO, et al. 2000. Elderly onset rheumatoid arthritis: clinical aspects. Clin. Exp. Rheumatol. 18: S49-S50.
6. CAPORALI, R., C. MONTECUCCO, O. EPIS, et al. 2001. Presenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis with PMR-like onset: a prospective study. Ann. Rheum. Dis. 60: 1021-1024.
7. CUTOLO, M., L. FOPPIANI & F. MINUTO. 2002. Hypothalamic-pituitary- adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica. J. Endocrinol. Invest. 25: 19-23.
8. STRAUB, R.H., T. GLUCK, M. CUTOLO, et al. 2000. The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumour necrosis factor) in polymyalgia rheumatica. Rheumatology 39: 624-631.
9. CUTOLO, M., R.H. STRAUB, L. FOPPIANI, et al. 2002. Adrenal gland hypofunction in active polymyalgia rheumatica. Effect of glucocorticoid treatment on adrenal hormones and interleukin-6. J. Rheumatol. 29: 748-756.
10. CHUANG, T.Y., G.G. HUNDER, D.M. ILSTRUP, et al. 1982. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann. Intern. Med. 97: 672-680.
11. ARNETT, F.C., S.M. EDWORTHY, DA. BLOCK, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31: 315-324.
12. WEYAND, C.M., J.W. FULBRIGHT, J.M. EVANS, et al. 1999. Corticosteroid requirements in polymyalgia rheumatica. Arch. Intern. Med. 159: 577-584.
13. LIANG, G.C., P.A. SIMKIN, G.G. HUNDER, et al. 1974. Familial aggregation of polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum. 17: 19-24.
14. SALVARANI, C., P.L. MACCHIONI, F. ZIZZI, et al. 1991. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in Northern Italy. Arthritis Rheum. 34: 351-356.
15. SALVARANI, C., B. CASALI, L. BOIARDI, et al. 2000. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity. J. Rheumatol. 27: 1215-1221.
16. MATTEY, D.L., A.H. HAJEER, A. DABABNEH, et al. 2000. Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms. Arthritis Rheum. 43: 1749-1755.
17. BOIARDI, L., C. SALVARANI, J.M. TIMMS, et al. 2000. Interleukin-1 cluster and tumor necrosis factor-α gene polymorphisms in polymyalgia rheumatica. Clin. Exp. Rheumatol. 18: 675-681.
18. JAATTELA, M., V. ILVESMAKI, R. VOUTILAINEN, et al. 1991. Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology 128: 623-629.
19. HERRMANN, M., J. SCHOLMERICH & R.H. STRAUB. 2002. Influence of cytokines and growth factors on distinct steroidogenic enzymes in vitro: a short tabular data collection. Ann. N. Y. Acad. Sci. 966: 166-186.
20. CUTOLO, M., A. SULLI, C. PIZZORNI, et al. 2003. Hypothalamic-pituitary- adrenocortical and gonadal functions in rheumatoid arthritis. Ann. N. Y. Acad. Sci. 992: 107-117.
21. CUTOLO, M., B. VILLAGGIO, L. FOPPIANI, et al. 2000. The hypothalamic-pituitary-adrenal and gonadal axes in rheumatoid arthritis. Ann. N. Y Acad. Sci. 917: 835-843.
22. STRÄUB, R.H., M. ZEUNER, E. ANTONIOU, et al. 1996. Dehydroepiandrosterone sulfate is positively correlated with soluble interleukin 2 receptor and soluble intercellular adhesion molecule in systemic lupus erythematosus. J. Rheumatol. 23: 856-861.
23. STRAUB, R.H., D. VOGL, V. GROSS, et al. 1998. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease. Am. J. Gastroenterol. 93: 2197-2202.